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SUMMARY 
The natural anabolic agent (Lactoferrin) has been shown to 
increase bone growth. However, its effects on bone 
architecture and net bone strength are less conclusive. A cell 
model which describes the rates of bone volume turnover in 
response to osteoblast and osteoclast generation was modified 
to account for the influence of Lacotoferrin. The bone 
microstructure was imaged using CT and a virtual 
computational model developed to capture the micro-
architecture and density variation. The cell model was then 
coupled to the micro-level model to drive the amount of bone 
growth and resorption in response to strain stimuli. This in 
turn drives bone adaption and changing micro architecture. 
The evolved bone was then loaded to determine net bone 
strength. The resulting bone was shown to have increased 
bone density and improved architecture to give improved 
overall bone strength. The proposed framework can 
potentially evaluate and test bone strengthening treatments and 
be used to inform clinical trials.  
 
INTRODUCTION 
Numerous computational bone models have explored 
remodelling and bone response at either the cell level [1], 
micro level [2] or macro level (whole bone) [3]. There have 
been limited attempts to link information across these spatial 
scales [4]. This is important as diseases and associated 
therapies are best introduced at the cell level. Treatment 
examples include fluoride therapy [5] and milk-derived 
Lactoferrin therapy [6], both shown to increase mineralised 
bone. They operate by directly or indirectly influencing the 
bone absorbing cells (osteoclasts) and bone forming cells 
(osteoblasts). This, in turn, changes the micro bone 
architecture and the overall continuum strength observed at 
the whole bone level. The focus of this study, Lactoferrin 
therapy, acts by increasing the number of osteoblasts and 
inhibiting osteoclastogenesis (the precursor to osteoblasts). 
The aim of this study was to (i) observe strain-based bone 
remodelling due to modified availability of osteoblasts and 
osteoclasts from Lactoferrin; and (ii) evaluate the macro 
strength of the Lactoferrin bone compared to a control bone. 
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Figure 1:  Bone remodelling framework showing (i) 
Computed Tomography (CT) of the cortical and trabecular 
bone from the Femur with an isolated cortical cube region 
identified for Synchrotron imaging. (ii) A Cell model based on 
the RANK-RANKL-OPG pathway for predicting the 
availability of osteoblasts and osteoclasts for remodelling at 
the micro level. (iii) The Synchrotron imaged bone cube is 
transformed into the equivalent SPH geometry and 
remodelling occurs stimulated by the local strain pattern. (iv) 
Motion capture experiments are performed on a customised 
whole body model and physiological loads computed. (v) The 
loads are then scaled to the micro level at the femoral neck 
region of interest to act as boundary conditions for the micro 
SPH model 
 
Figure 1 shows the multiscale modelling framework 
developed as part of the IUPS Physiome project used to link 
the spatial scales [7, 8]. At the cell level the bone remodelling 
process describing the RANK-RANKL-OPG pathway was 
implemented in CellML [1, 9, 10]. This describes the amount 
of osteoblasts (bone forming) and osteoclasts (bone resorbing) 
cells in response to a healthy, diseased or treatment state. At 
the micro level a particulate method (SPH) was used to model 
the geometry of a 1mm
3
 size bone. At this level a bone 
remodelling algorithm based on strain excitation adapted from 
the work of Prendergast [12] was used to add or remove bone 
in order to maintain bone density. At this level the osteon 
cortical pore structure was visible and the bone growth and 
resorption patterns based on the number of 
osteoclasts/osteoblasts lead to a changing architecture and 
overall bone strength. Micro level models were built at 
strategic sites of interest (femoral shaft, femoral neck and the 
femoral head). 
The macro model (whole bone) was a Femur 
geometry from the AnatML database, which is scaled to the 
subject of interest using free-form deformation [13]. A 
spatially varying density and young’s modulus is fitted from 
CT images using the CT number and a grey-scale mapping. 
The macro level models are physiologically loaded from 
muscles force and ground reaction force data, taken from gait 
data [14]. The whole bone model provides the boundary 
conditions for the micro models.  
In a two-way coupling, the averaged strength from 
each of the micro models is combined and fitted to the whole 
femur continuum to reflect the changed bone strength.  
  
RESULTS AND DISCUSSION  
 
Figure 2:  (left) Cortical bone strain pattern in 69 year old 
subject; (middle) remodelling with Lacotoferrin influence 
showing reduced bone absorption; and (right) remodelling 
with no Lactoferrin influence showing increased bone 
absorption and pore merging.  
 
The model was tested on a 69 year old subject, whose cortical 
bone structure is shown in Figure 2. The Von Mises strain 
pattern in Figure 2 (left) shows regions of localised strain 
shielding where Haversion cannals are close to one another 
(highlighted by circles). This condition has been shown to lead 
to pore merging [15] and the formation of ‘super osteons’, 
which weakens the integrity of the bone and reduces strength. 
Figure 2 (middle) shows simulated remodelling after 30 
months with Lactoferrin. There is very little change in the 
osteon pattern. Figure 2 (right) shows simulated remodelling 
without Lactoferrin where the rate of bone removal is higher 
than bone deposition. The Haversion cannals start to grow 
forming long fragmented structures. These structures merge 
forming larger pores that contribute to the reduction in bone 
strength. The bone configuration in Figure 2 (right) is already 
starting to buckle slightly under this load. 
This means that in the control model the region of 
strain shielding gives rise to a net bone absorption due to the 
strain pattern. The effect of Lactoferrin is to stagnate this 
process. Given that we have chosen an arbitrary influence 
from the Lactoferrin this may have slowed or even added 
bone. The main benefit is that with less osteoclasts available 
the bone structure is maintained longer. Secondly, when the 
average strength was measured the Lactoferrin bone was 
enough to maintain the shape of the specimen, while the 
control started to buckle. At the femoral neck, this could 
potentially lead to catastrophic failure. 
 
CONCLUSIONS 
Lactoferrin is known to proliferate the number of osteoblasts 
and inhibit osteoclastogenesis (the precursor to osteoclast 
formation). This has the net effect of increased bone growing 
potential while inhibiting bone resorption. This study showed 
that in elderly bone where bone resportion is higher due to the 
the strain shielding arising from the close arrangement of 
Haversion cannals, Lactoferrin slowed the resorption of bone 
significantly. This maintained the integrity of the bone 
architecture. In contrast, the control bone showed net bone 
loss, merging of osteon pores and a weakened structure that 
started to buckle.   
 The presented modelling framework is limited in that 
it currently responds only to strain excitation and does not 
include damage remodelling, which may dominate the bones 
response. Secondly, the model assumes a constant steady-state 
boundary condition, however, the model is capable of 
handling a periodic loading, such as that experienced during 
gait.   
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